US Food and Drug Administration (FDA)

Trends In Artificial Pancreas Technologies And Future Directions

Diabetes is a chronic condition that affects millions of people worldwide. The condition requires close and careful management to avoid severe health consequences. Today, people with diabetes have access to sophisticated automated insulin dosing (AID) systems that help in many aspects of diabetes management. IDTechEx forecasts that with further developments in AID systems, the diabetes management market can reach US$44 billion by 2035.

Development of Closed-Loop Insulin Systems

Innovation map for development of closed-loop insulin systems.

Insulin Delivery

Innovation map for insulin delivery.

Non-Invasive Glucose Monitoring

Innovation map of non-invasive glucose monitoring.

Wi-Charge

Wi-Charge, an Israel-based company, develops long-range wireless charging technology for both commercial and residential applications. IDTechEx interviewed Ori Mor, Wi-Charge's Chief Business Officer, to explore their technology, business model, and planned advancements.

CamDiab

CamDiab Ltd is a UK-based startup that has developed the CamAPS FX, a smartphone app for hybrid closed-loop adjustment of insulin for people with Type 1 diabetes.

Senseonics

Senseonics is a US medical device company which has commercialized the Eversense implantable continuous glucose monitor.

Insulet

Insulet is a US-based medical device company that develops and sells a wearable and tubeless infusion pump. The company has commercialized the Omnipod series of insulin patch pumps.

University of Binghamton: Bioelectronics and Microsystems Lab

IDTechEx spoke to Zahra Rafiee, lead PhD student in the Bioelectronics and Microsystems Lab at Binghamton University. The group has developed a paper based circuit board which includes biodegradable components.

Precision Neuroscience

Precision Neuroscience is developing a flexible thin-film electrode array for brain-computer interfacing inserted with a minimally invasive surgery.

Paradromics, Inc

Paradromics are developing an invasive brain computer interface (BCI) based on micro-electrode arrays.

Synchron

Synchron are developing a minimally invasive brain-computer interfacing solution.